AI
Acuitas Investments Portfolio holdings
AUM
$126M
This Quarter Return
+4.56%
1 Year Return
+52.6%
3 Year Return
+222.31%
5 Year Return
+667.82%
10 Year Return
–
AUM
$170M
AUM Growth
+$170M
(-0.95%)
Cap. Flow
+$2.6M
Cap. Flow
% of AUM
1.53%
Top 10 Holdings %
Top 10 Hldgs %
25.49%
Holding
122
New
16
Increased
33
Reduced
44
Closed
7
Top Buys
| 1 |
CHS
Chicos FAS, Inc.
CHS
|
$2.6M |
| 2 |
INVX
Innovex International, Inc.
INVX
|
$2.2M |
| 3 |
Oportun Financial
OPRT
|
$2.08M |
| 4 |
Orion Group Holdings
ORN
|
$1.86M |
| 5 |
Ramaco Resources Class B
METCB
|
$1.79M |
Top Sells
| 1 |
Sterling Infrastructure
STRL
|
$3.1M |
| 2 |
Natural Gas Services Group
NGS
|
$1.99M |
| 3 |
Skywest
SKYW
|
$1.86M |
| 4 |
Powell Industries
POWL
|
$1.64M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$1.41M |
Sector Composition
| 1 | Industrials | 14.73% |
| 2 | Technology | 12.99% |
| 3 | Healthcare | 12.08% |
| 4 | Energy | 11.93% |
| 5 | Consumer Staples | 11.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fulcrum Therapeutics
FULC
$351M
| $599K | 0.35% |
134,811
-4
| -0% | -$18 |
|
77
Riskified
RSKD
$748M
| $569K | 0.33% |
+126,925
| New | +$569K |
|
78
Arteris
AIP
$402M
| $562K | 0.33% |
86,299
+21,946
| +34% | +$143K |
|
79
Tourmaline Bio
TRML
$601M
| $547K | 0.32% |
194,547
-296,594
| -60% | -$833K |
|
80
Astrotech Corp
ASTC
$8.72M
| $534K | 0.31% |
52,947
+9,638
| +22% | +$97.3K |
|
81
AMREP Corp
AXR
$114M
| $520K | 0.31% |
30,906
-1
| -0% | -$17 |
|
|
LENZ
82
LENZ Therapeutics
LENZ
$1.12B
| $485K | 0.29% |
195,762
-7
| -0% | -$17 |
|
83
Reading International Class A
RDI
$35.1M
| $479K | 0.28% |
226,084
-3
| -0% | -$6 |
|
84
Bolt Biotherapeutics
BOLT
$9.85M
| $479K | 0.28% |
460,379
-6
| -0% | -$6 |
|
85
Rafael Holdings
RFL
$48.4M
| $444K | 0.26% |
233,432
+8
| +0% | +$15 |
|
|
CMRX
86
DELISTED
Chimerix, Inc.
CMRX
| $439K | 0.26% |
457,791
-26
| -0% | -$25 |
|
87
Adverum Biotechnologies
ADVM
$64.6M
| $437K | 0.26% |
291,169
-322,159
| -53% | -$483K |
|
88
Nektar Therapeutics
NKTR
$553M
| $430K | 0.25% |
721,460
-33
| -0% | -$20 |
|
|
KRON
89
DELISTED
Kronos Bio
KRON
| $427K | 0.25% |
328,821
-12
| -0% | -$16 |
|
90
Nuvation Bio
NUVB
$1.01B
| $424K | 0.25% |
316,499
-18
| -0% | -$24 |
|
|
LUMO
91
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $413K | 0.24% |
125,242
-28,625
| -19% | -$94.5K |
|
92
TAT Technologies
TATT
$448M
| $399K | 0.23% |
46,422
-17,514
| -27% | -$151K |
|
93
CKX Lands
CKX
$23.7M
| $385K | 0.23% |
29,318
-3,961
| -12% | -$52K |
|
|
SHPW
94
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
| $383K | 0.23% |
119,507
-4
| -0% | -$13 |
|
|
ADAP
95
Adaptimmune Therapeutics
ADAP
$15.3M
| $374K | 0.22% |
+479,764
| New | +$374K |
|
96
Atea Pharmaceuticals
AVIR
$267M
| $370K | 0.22% |
123,427
-3
| -0% | -$9 |
|
97
NextCure
NXTC
$13.5M
| $370K | 0.22% |
286,817
-17
| -0% | -$22 |
|
98
Invivyd
IVVD
$216M
| $355K | 0.21% |
+208,579
| New | +$355K |
|
|
RAIN
99
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $353K | 0.21% |
+409,256
| New | +$353K |
|
100
Coda Octopus Group
CODA
$91.2M
| $328K | 0.19% |
+52,925
| New | +$328K |
|